Form 8-K - Current report:
SEC Accession No. 0001193125-25-263534
Filing Date
2025-11-04
Accepted
2025-11-04 07:05:25
Documents
12
Period of Report
2025-11-04
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d20656d8k.htm   iXBRL 8-K 26649
  Complete submission text file 0001193125-25-263534.txt   141616

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA phat-20251104.xsd EX-101.SCH 2866
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE phat-20251104_lab.xml EX-101.LAB 17992
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phat-20251104_pre.xml EX-101.PRE 11271
14 EXTRACTED XBRL INSTANCE DOCUMENT d20656d8k_htm.xml XML 3646
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

EIN.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39094 | Film No.: 251446403
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)